Radiopharm Theranostics Ltd 6-K, filed Sep 11, 2026
Radiopharm Theranostics Ltd (RADX)
About this 6-K
Radiopharm Theranostics Ltd filed this 6-K on September 11, 2026.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the Month of September 2026
Commission File Number: 001-41621
RADIOPHARM THERANOSTICS LIMITED
(Name of Registrant)
Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
RADIOPHARM THERANOSTICS LIMITED
EXPLANATORY NOTE
Radiopharm Theranostics Limited (the “Company”) published one announcement (the “Public Notice”) to the Australian Securities Exchange on September 11, 2026 titled:
“Results of Meeting”
A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.
This report on Form 6-K (including any exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any registration statement or prospectus under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such registration statement or prospectus.
1
EXHIBITS
| Exhibit Number |
Description | |
| 99.1 | Results of Meeting |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| RADIOPHARM THERANOSTICS LIMITED | ||
| Date: September 11, 2026 | By: | /s/ Amritha Sushil |
| Amritha Sushil | ||
| Company Secretary | ||
3
Exhibit 99.1
| ASX ANNOUNCEMENT |  |
| 11 September 2026 |
Results of General Meeting
Sydney, Australia – Friday, 11 September 2026 – Radiopharm Theranostics Limited (ASX: RAD; Nasdaq: RADX) advises that all resolutions considered at the General Meeting held today were carried by poll.
In accordance with ASX Listing Rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.
Amritha Sushil
Joint Company Secretary
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
ABN: 57 647 877 889
|
Disclosure of Proxy Votes Radiopharm Theranostics Limited Extraordinary General Meeting Friday, 11 September 2026 |
GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 |
In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.
| Proxy Votes | Poll Results (if applicable) | Results | ||||||||||||||||||||||||||||||
| Resolution | Decided by Show of Hands (S) or Poll (P) | Total Number of Proxy Votes exercisable by proxies validly appointed | FOR | AGAINST | ABSTAIN | PROXY'S DISCRETION | FOR | AGAINST | ABSTAIN | OUTCOME | ||||||||||||||||||||||
| 1a Ratification of prior issue of First Tranche Placement Shares to Placement Participants | P | 1,221,986,356 | 1,187,939,605 97.21% | 32,644,514 2.67% | 12,057,450 | 1,402,237 0.11% | 1,189,341,842 97.33% | 32,644,514 2.67% | 12,057,450 |
Carried | ||||||||||||||||||||||
| 1b Ratification of prior issue of ADS Shares to US Participants | P | 1,221,353,323 | 1,212,284,305 99.26% | 8,900,114 0.73% | 12,690,483 | 168,904 0.01% | 1,212,453,209 99.27% | 8,900,114 0.73% | 12,690,483 |
Carried | ||||||||||||||||||||||
| 2 Approval to issue Second Tranche Placement Shares to Placement Participants | P | 1,220,753,023 | 1,181,642,005 96.80% | 38,942,114 3.19% | 13,290,783 | 168,904 0.01% | 1,181,810,909 96.81% | 38,942,114 3.19% | 13,290,783 |
Carried | ||||||||||||||||||||||
| 3 Approval to issue Placement Attaching Options to Placement Participants | P | 1,221,353,023 | 1,179,718,821 96.59% | 41,465,298 3.40% | 12,690,783 | 168,904 0.01% | 1,179,887,725 96.60% | 41,465,298 3.40% | 12,690,783 |
Carried | ||||||||||||||||||||||
| 4a Approval to issue SPP Shares to Eligible Shareholders | P | 1,222,586,656 | 1,183,318,738 96.79% | 39,099,014 3.20% | 11,457,150 | 168,904 0.01% | 1,183,487,642 96.80% | 39,099,014 3.20% | 11,457,150 |
Carried | ||||||||||||||||||||||
| 4b Approval to issue SPP Attaching Options to Eligible Shareholders | P | 1,221,926,656 | 1,180,363,554 96.60% | 41,394,198 3.39% | 12,117,150 | 168,904 0.01% | 1,180,532,458 96.61% | 41,394,198 3.39% | 12,117,150 |
Carried | ||||||||||||||||||||||
| 5 Approval to issue Shortfall Options | P | 1,220,693,323 | 1,178,775,321 96.57% | 41,749,098 3.42% | 13,350,483 | 168,904 0.01% | 1,178,944,225 96.58% | 41,749,098 3.42% | 13,350,483 |
Carried | ||||||||||||||||||||||
2
| Proxy Votes | Poll Results (if applicable) | Results | ||||||||||||||||||||||||||||||
| Resolution | Decided by Show of Hands (S) or Poll (P) | Total Number of Proxy Votes exercisable by proxies validly appointed | FOR | AGAINST | ABSTAIN | PROXY'S DISCRETION | FOR | AGAINST | ABSTAIN | OUTCOME | ||||||||||||||||||||||
| 6 Approval to issue ADR Warrants | P | 1,221,353,023 | 1,179,696,950 96.59% | 41,487,169 3.40% | 12,690,783 | 168,904 0.01% | 1,179,865,854 96.60% | 41,487,169 3.40% | 12,690,783 |
Carried | ||||||||||||||||||||||
| 7 Approval to issue Agent Warrants | P | 1,231,979,023 | 1,179,696,950 95.76% | 52,113,169 4.23% | 2,064,783 | 168,904 0.01% | 1,179,865,854 95.77% | 52,113,169 4.23% | 2,064,783 |
Carried | ||||||||||||||||||||||
| 8a Approval to issue SPP Shares and SPP Attaching Options to Director, Paul Hopper | P | 948,869,958 | 894,216,556 94.24% | 54,461,314 5.74% | 285,173,848 | 192,088 0.02% | 894,408,644 94.26% | 54,461,314 5.74% | 285,173,848 |
Carried | ||||||||||||||||||||||
| 8b Approval to issue SPP Shares and SPP Attaching Options to Director, Ian Turner | P | 1,116,328,635 | 1,062,156,879 95.15% | 53,979,668 4.84% | 117,715,171 | 192,088 0.02% | 1,062,348,967 95.16% | 53,979,668 4.84% | 117,715,171 |
Carried | ||||||||||||||||||||||
| 8c Approval to issue SPP Shares and SPP Attaching Options to Director, Bruce Goodwin | P | 1,118,859,230 | 1,064,537,474 95.14% | 54,129,668 4.84% | 115,184,576 | 192,088 0.02% | 1,064,729,562 95.16% | 54,129,668 4.84% | 115,184,576 |
Carried | ||||||||||||||||||||||
| 8d Approval to issue SPP Shares and SPP Attaching Options to Chief Executive Officer and Director Riccardo Canevari | P | 1,118,948,528 | 1,064,626,772 95.15% | 54,129,668 4.84% | 115,095,278 | 192,088 0.02% | 1,064,818,860 95.16% | 54,129,668 4.84% | 115,095,278 |
Carried | ||||||||||||||||||||||
3